Literature DB >> 26812650

Catastrophic medical expenditure risk.

Gabriela Flores1, Owen O'Donnell2.   

Abstract

We propose a measure of household exposure to particularly onerous medical expenses. The measure can be decomposed into the probability that medical expenditure exceeds a threshold, the loss due to predictably low consumption of other goods if it does and the further loss arising from the volatility of medical expenses above the threshold. Depending on the choice of threshold, the measure is consistent with a model of reference-dependent utility with loss aversion. Unlike the risk premium, the measure is only sensitive to particularly high expenses, and can identify households that expect to incur such expenses and would benefit from subsidised, but not actuarially fair, insurance. An empirical illustration using data from seven Asian countries demonstrates the importance of taking account of informal insurance and reveals clear differences in catastrophic medical expenditure risk across and within countries. In general, risk is higher among poorer, rural and chronically ill populations.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Asia; Catastrophic payments; Medical expenditures; Reference-dependent utility; Risk

Mesh:

Year:  2016        PMID: 26812650     DOI: 10.1016/j.jhealeco.2016.01.004

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  7 in total

1.  Combined social and private health insurance versus catastrophic out of pocket payments for private hospital care in Greece.

Authors:  Nikolaos Grigorakis; Christos Floros; Haritini Tsangari; Evangelos Tsoukatos
Journal:  Int J Health Econ Manag       Date:  2017-01-03

2.  Assessing the burden of medical impoverishment by cause: a systematic breakdown by disease in Ethiopia.

Authors:  Stéphane Verguet; Solomon Tessema Memirie; Ole Frithjof Norheim
Journal:  BMC Med       Date:  2016-10-21       Impact factor: 8.775

3.  The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.

Authors:  Natalie Carvalho; Dennis Petrie; Linkun Chen; Joshua A Salomon; Philip Clarke
Journal:  Int J Equity Health       Date:  2019-04-16

4.  The household economic burden of non-communicable diseases in 18 countries.

Authors:  Adrianna Murphy; Benjamin Palafox; Marjan Walli-Attaei; Timothy Powell-Jackson; Sumathy Rangarajan; Khalid F Alhabib; Alvaro Jr Avezum; Kevser Burcu Tumerdem Calik; Jephat Chifamba; Tarzia Choudhury; Gilles Dagenais; Antonio L Dans; Rajeev Gupta; Romaina Iqbal; Manmeet Kaur; Roya Kelishadi; Rasha Khatib; Iolanthe Marike Kruger; Vellappillil Raman Kutty; Scott A Lear; Wei Li; Patricio Lopez-Jaramillo; Viswanathan Mohan; Prem K Mony; Andres Orlandini; Annika Rosengren; Ismail Rosnah; Pamela Seron; Koon Teo; Lap Ah Tse; Lungiswa Tsolekile; Yang Wang; Andreas Wielgosz; Ruohua Yan; Karen E Yeates; Khalid Yusoff; Katarzyna Zatonska; Kara Hanson; Salim Yusuf; Martin McKee
Journal:  BMJ Glob Health       Date:  2020-02-11

5.  Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures.

Authors:  Abdulrahman Jbaily; Annie Haakenstad; Mizan Kiros; Carlos Riumallo-Herl; Stéphane Verguet
Journal:  Eur J Health Econ       Date:  2021-08-06

6.  Comparative health systems analysis of differences in the catastrophic health expenditure associated with non-communicable vs communicable diseases among adults in six countries.

Authors:  Annie Haakenstad; Matthew Coates; Gene Bukhman; Margaret McConnell; Stéphane Verguet
Journal:  Health Policy Plan       Date:  2022-10-12       Impact factor: 3.547

7.  Valuing Protection against Health-Related Financial Risks.

Authors:  Jonathan Skinner; Kalipso Chalkidou; Dean T Jamison
Journal:  J Benefit Cost Anal       Date:  2019-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.